Showing 1,641 - 1,660 results of 4,121 for search 'significantly ((((lower decrease) OR (teer decrease))) OR (larger decrease))', query time: 0.34s Refine Results
  1. 1641

    Descriptive data for the pBT-child dyads. by Madalina Ciobanu (2504683)

    Published 2025
    “…<div><p>Autism spectrum disorder (ASD) is a condition with growing prevalence that results in significant healthcare spending, reduced parent income, high levels of family stress, and decreased quality of life (QoL). …”
  2. 1642

    CFQL-2 descriptive statistics. by Madalina Ciobanu (2504683)

    Published 2025
    “…<div><p>Autism spectrum disorder (ASD) is a condition with growing prevalence that results in significant healthcare spending, reduced parent income, high levels of family stress, and decreased quality of life (QoL). …”
  3. 1643

    O<sub>2</sub> concentration under different conditions. by Zihao Chai (20521844)

    Published 2025
    “…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …”
  4. 1644

    This is the paper’s data. by Zihao Chai (20521844)

    Published 2025
    “…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …”
  5. 1645

    O<sub>2</sub> concentration under different conditions. by Zihao Chai (20521844)

    Published 2025
    “…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …”
  6. 1646
  7. 1647
  8. 1648
  9. 1649
  10. 1650
  11. 1651
  12. 1652
  13. 1653

    Participant flow (CONSORT diagram). by David J. Diemert (8135568)

    Published 2024
    “…Peak anti-<i>Na</i>-GST-1 IgG levels were observed between 2 and 4 weeks following the third dose, regardless of <i>Na</i>-GST-1 formulation. IgG levels decreased but remained significantly above baseline in all groups by day 290, at which point all participants (20 of 20 evaluable participants) still had detectable IgG. …”
  14. 1654
  15. 1655

    Study data. by Jie Liu (15128)

    Published 2025
    “…The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. The infection rate of COVID-19 and the mortality rate caused by COVID-19 were lower in roxadustat group.…”
  16. 1656

    Summary of clinical outcomes after 9 months. by Jie Liu (15128)

    Published 2025
    “…The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. The infection rate of COVID-19 and the mortality rate caused by COVID-19 were lower in roxadustat group.…”
  17. 1657

    Approval by the research ethics committee. by Jie Liu (15128)

    Published 2025
    “…The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. The infection rate of COVID-19 and the mortality rate caused by COVID-19 were lower in roxadustat group.…”
  18. 1658
  19. 1659
  20. 1660